LeMaitre CFO to Present at Three Investor Conferences in September

  • LeMaitre Vascular CFO Dorian LeBlanc will participate in three investor conferences in September 2026.
  • First event: Wells Fargo 21st Annual Healthcare Conference on September 8, 2026, in Boston.
  • Second event: Morgan Stanley 24th Annual Global Healthcare Conference on September 16, 2026, in New York City.
  • Third event: 19th Annual Barrington Research Virtual Fall Investment Conference on September 22, 2026.

LeMaitre Vascular's participation in multiple investor conferences suggests a focused effort to engage with the financial community amid a competitive landscape in the medical devices sector. The peripheral vascular disease market, which affects over 200 million people globally, remains a key growth area, and LeMaitre's strategic positioning will be under scrutiny.

Market Perception
How LeBlanc's presentations will influence investor sentiment towards LeMaitre Vascular.
Strategic Messaging
Whether LeMaitre will use these conferences to signal new growth initiatives or operational shifts.
Competitive Positioning
The pace at which LeMaitre can differentiate itself in the peripheral vascular disease market.